152 related articles for article (PubMed ID: 35850983)
21. Impact of changes in Achilles tendon thickening on cardiovascular events in patients with familial hypercholesterolemia.
Tada H; Kojima N; Takeji Y; Nohara A; Kawashiri MA; Takamura M
Am J Prev Cardiol; 2024 Jun; 18():100660. PubMed ID: 38590629
[TBL] [Abstract][Full Text] [Related]
22. Relationship between serum uric acid levels and the incidence of cardiovascular events after percutaneous coronary intervention.
Matsumoto I; Moriya S; Kurozumi M; Namba T; Takagi Y
J Cardiol; 2021 Dec; 78(6):550-557. PubMed ID: 34479787
[TBL] [Abstract][Full Text] [Related]
23. Lower Baseline LDL Cholesterol Affects All-cause Mortality in Patients with First Percutaneous Coronary Intervention.
Chen X; Chen H; Lu Wei B; Zhang M; Tao Y; Wang QC; Fu GS; Zhang WB
Biomed Environ Sci; 2023 Apr; 36(4):324-333. PubMed ID: 37105907
[TBL] [Abstract][Full Text] [Related]
24. Extent of lipid core plaque in patients with Achilles tendon xanthoma undergoing percutaneous coronary intervention for coronary artery disease.
Kitahara H; Yamazaki T; Hiraga T; Yamashita D; Matsumoto T; Kobayashi T; Sato T; Suzuki M; Saito K; Matsuoka T; Mori N; Tateishi K; Fujimoto Y; Kobayashi Y
J Cardiol; 2022 Apr; 79(4):559-563. PubMed ID: 34895790
[TBL] [Abstract][Full Text] [Related]
25. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
26. In-hospital and 1-Year Outcomes of Repeated Percutaneous Coronary Intervention for In-stent Restenosis With Acute Coronary Syndrome Presentation.
Nozari Y; Mojtaba Ghorashi S; Alidoust M; Hamideh Mortazavi S; Jalali A; Omidi N; Fazeli A; Aghajani H; Salarifar M; Reza Amirzadegan A
Crit Pathw Cardiol; 2022 Jun; 21(2):87-92. PubMed ID: 35416802
[TBL] [Abstract][Full Text] [Related]
27. Real-world study of low-density lipoprotein cholesterol levels and cardiovascular outcomes in Chinese: A retrospective cohort study in post-percutaneous coronary intervention acute coronary syndrome patients.
Wang Y; Yan BP; Nichol MB; Tomlinson B; Lee VWY
Int J Cardiol; 2017 Dec; 249():18-24. PubMed ID: 29121725
[TBL] [Abstract][Full Text] [Related]
28. Impact of serum albumin levels on long-term outcomes in patients undergoing percutaneous coronary intervention.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
Heart Vessels; 2017 Sep; 32(9):1085-1092. PubMed ID: 28429111
[TBL] [Abstract][Full Text] [Related]
29. Contributors to newly developed coronary artery disease in patients with a previous history of percutaneous coronary intervention beyond the early phase of restenosis.
Endo A; Yoshida Y; Kageshima K; Sato H; Suga T; Nasu H; Takahashi N; Tanabe K
Intern Med; 2014; 53(8):819-28. PubMed ID: 24739601
[TBL] [Abstract][Full Text] [Related]
30. Long-term clinical impact of low-density lipoprotein cholesterol target attainment according to lesion complexity after percutaneous coronary intervention.
Kim BJ; Lee JH; Park JI; Nam JH; Lee CH; Son JW; Kim U; Shin DG; Park JS
Coron Artery Dis; 2022 Aug; 33(5):368-375. PubMed ID: 35131985
[TBL] [Abstract][Full Text] [Related]
31. Association of major adverse cardiovascular events and cardiac troponin-I levels following percutaneous coronary intervention: a three-year follow-up study at a single center.
Huang ZS; Zheng ZD; Zhang JW; Tang LL; Zhou LL; Li SH; Xie XJ; Dong RM; Zhu JM; Liu JL
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3981-3992. PubMed ID: 32329875
[TBL] [Abstract][Full Text] [Related]
32. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
Perera D; Crake T; Lee V
Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
[TBL] [Abstract][Full Text] [Related]
33. The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia.
Michikura M; Hori M; Ogura M; Hosoda K; Harada-Shiba M
Atherosclerosis; 2022 Oct; 358():41-46. PubMed ID: 36087353
[TBL] [Abstract][Full Text] [Related]
34. Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention.
Furtado RHM; Fagundes AA; Oyama K; Zelniker TA; Tang M; Kuder JF; Murphy SA; Hamer A; Wang H; Keech AC; Giugliano RP; Sabatine MS; Bergmark BA
Circ Cardiovasc Interv; 2022 Mar; 15(3):e011382. PubMed ID: 35209731
[TBL] [Abstract][Full Text] [Related]
35. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
[TBL] [Abstract][Full Text] [Related]
36. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
Choi DH; Kobayashi Y; Nishi T; Kim HK; Ki YJ; Kim SS; Park KH; Song H; Fearon WF
Angiology; 2019 Apr; 70(4):345-351. PubMed ID: 29631419
[TBL] [Abstract][Full Text] [Related]
37. Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
Fukutomi M; Toriumi S; Ogoyama Y; Oba Y; Takahashi M; Funayama H; Kario K
Catheter Cardiovasc Interv; 2019 Apr; 93(5):E262-E268. PubMed ID: 30244539
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.
Harada-Shiba M; Ako J; Arai H; Hirayama A; Murakami Y; Nohara A; Ozaki A; Uno K; Nakamura M
Atherosclerosis; 2018 Oct; 277():362-368. PubMed ID: 30270072
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
[TBL] [Abstract][Full Text] [Related]
40. Incomplete Revascularization Is Associated With an Increased Risk for Major Adverse Cardiovascular Events Among Patients Undergoing Noncardiac Surgery.
Armstrong EJ; Graham LA; Waldo SW; Valle JA; Maddox TM; Hawn MT
JACC Cardiovasc Interv; 2017 Feb; 10(4):329-338. PubMed ID: 28161261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
